Stay updated on Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page revision tag was updated to v3.5.4, replacing the previous v3.5.3. This denotes a minor page update without altering the study content or public details.
    Difference
    0.0%
    Check dated 2026-05-16T09:29:08.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The page’s footer revision/version indicator has been updated from v3.5.2 to v3.5.3.
    Difference
    0.0%
    Check dated 2026-04-24T16:50:02.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Revision updated to v3.5.2 (replacing v3.5.0).
    Difference
    0.0%
    Check dated 2026-04-17T13:35:04.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Status updated from Active, not recruiting to Completed with completion date 2026-02-12, and page revision updated to Revision: v3.5.0.
    Difference
    0.3%
    Check dated 2026-03-19T19:19:47.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. This is a minor update with no changes to essential study information.
    Difference
    0.0%
    Check dated 2026-03-12T14:41:00.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Removed the lay language results summary, sponsor attribution (Ipsen), and the 'Helpful Links Provided by' section from the Study Details page.
    Difference
    0.1%
    Check dated 2026-02-19T01:50:28.000Z thumbnail image

Stay in the know with updates to Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial page.